Brief: Acurx Pharmaceuticals Inc Reports Third Quarter 2022 Results And Provides Business Update
14/11/2022 13:22
Nov 14 (Reuters) - Acurx Pharmaceuticals Inc ACXP.O :
* ACURX PHARMACEUTICALS, INC. REPORTS THIRD QUARTER 2022
RESULTS
AND PROVIDES BUSINESS UPDATE
* ACURX PHARMACEUTICALS INC - REPORTED A NET LOSS OF $3.5
MILLION
OR $0.32 PER DILUTED SHARE FOR THREE MONTHS ENDED SEPTEMBER 30,
2022
Source text for Eikon: ID:nPn6Rvl5Ta
Further company coverage: ACXP.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Acurx Pharmaceuticals
See all newsAcurx Pharmaceuticals Q1 net loss narrows as expenses fall
Brief: Acurx Pharmaceuticals To Discuss First Quarter 2026 Financial Results On May 12, 2026 Conference Call And Provide Business Update
Brief: Acurx Pharmaceuticals, Inc. Announces Closing Of Up To $7.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Acurx Pharmaceuticals Q4 net loss narrows on lower R&D spend
Acurx Pharma Q3 net loss narrows to $2 mln